Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
boston top stories
crispr therapeutics
3
×
crispr-cas9
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
cancer
editas medicine
gene editing
intellia therapeutics
national
agios therapeutics
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
base editing
boston
boulder/denver blog main
boulder/denver top stories
branden moriarty
brexanolone
broad institute
camp4 therapeutics
cancer immunotherapy
cas13
clinical trials
crispr
david liu
deals
denali therapeutics
detroit blog main
detroit top stories
dna
editas
editor
What
cancer
cas
crispr
editing
gene
medicine
potential
today
ahead
ambien
american
annual
asco
attendees
attention
beam
biotech
camp’s
cash
cells
chicago
city
clinical
combinations
community’s
days
defect
drive
drug
editas
edited
editor
expanding
fears
flag
focus
founders
genetic
gotten
guardian
Language
Current search:
crispr-cas9
×
photo
×
" crispr therapeutics "
×
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M